Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma
Clinical trial NCT03367715 · COMPLETED
Trial details
- NCT number
- NCT03367715
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2021-05-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.